(Q46412981)

22 December 2017

title

Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML. (English)

1 reference

22 December 2017

1 reference

2

R Storb

1 reference

22 December 2017

F R Kerbauy

1

1 reference

22 December 2017

U Hegenbart

3

1 reference

22 December 2017

T Gooley

4

1 reference

22 December 2017

J Shizuru

5

1 reference

22 December 2017

H K Al-Ali

6

1 reference

22 December 2017

J P Radich

7

1 reference

22 December 2017

D G Maloney

8

1 reference

22 December 2017

E Agura

9

1 reference

22 December 2017

B Bruno

10

1 reference

22 December 2017

E M Epner

11

1 reference

22 December 2017

T R Chauncey

12

1 reference

22 December 2017

K G Blume

13

1 reference

22 December 2017

D Niederwieser

14

1 reference

22 December 2017

B M Sandmaier

15

1 reference

22 December 2017

publication date

1 June 2005

1 reference

22 December 2017

published in

Leukemia

1 reference

22 December 2017

volume

19

1 reference

22 December 2017

issue

6

1 reference

22 December 2017

page(s)

990-997

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403730

exact match

0 references

cites work

Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403730

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403730

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403730

Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403730

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403730

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403730

Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403730

Acyclovir prophylaxis of herpes-simplex-virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403730

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403730

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403730

Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403730

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403730

Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403730

Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403730

The graft-versus-leukemia effect of nonmyeloablative stem cell allografts may not be sufficient to cure chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403730

BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403730

Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403730

Use of a reduced-intensity conditioning regimen for allogeneic transplantation in patients with chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403730

Marrow transplantation for the treatment of chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403730

7 January 2021

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403730

7 January 2021

Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403730

7 January 2021

A comparative study of HLA-DRB1 typing by standard serology and hybridization of non-radioactive sequence-specific oligonucleotide probes to PCR-amplified DNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403730

7 January 2021

Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403730

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403730

1 reference

22 December 2017

PubMed ID

15800667

1 reference

22 December 2017